Gallardo, E. http://orcid.org/0000-0002-1375-3488
Medina, J.
Sánchez, J. C.
Viúdez, A.
Grande, E.
Porras, I.
Ramón y Cajal, T.
Trigo, J.
Iglesias, L.
Capdevila, J.
Article History
Received: 27 December 2019
Accepted: 27 December 2019
First Online: 31 January 2020
Compliance with ethical standards
:
: <b>Dr. Gallardo</b> reports personal fees and non-financial support from Eisai, personal fees and non-financial support from Bayer, during the conduct of the study; grants, personal fees and non-financial support from Astellas, grants, personal fees and non-financial support from Janssen, grants, personal fees and non-financial support from Sanofi, grants, personal fees and non-financial support from Bayer, grants, personal fees and non-financial support from Ipsen, personal fees and non-financial support from Roche, grants from Ferrer, grants from GSK, personal fees from Novartis, personal fees and non-financial support from Pfizer, personal fees and non-financial support from BMS, personal fees from EUSA Pharma, personal fees and non-financial support from Rovi, personal fees and non-financial support from Daiichi Sankyo, personal fees and non-financial support from Leo Pharma, personal fees from Techdow, personal fees and non-financial support from Menarini, personal fees and non-financial support from AstraZeneca, personal fees from Boehringer, personal fees from Merck, personal fees from MSD, outside the submitted work. <b>Dr. Medina</b> reports grants, personal fees and non-financial support from Roche, grants, personal fees and non-financial support from Novartis, grants, personal fees and non-financial support from BMS, personal fees and non-financial support from Pierre Fabre, personal fees and non-financial support from MSD, outside the submitted work. <b>Dr. Sánchez</b> reports personal fees (meeting and travel support) from Pierre Fabre and Boehringer Ingelheim; personal fees from Roche; personal fees (advisory board, consultancy, speaker honoraria or travel support) from Eisai, Sanofi, Bristol-Myers Squibb, MSD, Merck Serono and Kyowa Kirin, outside the submitted work. <b>Dr. Viúdez</b> has nothing to disclose. <b>Dr. Grande</b> reports grants from Roche, grants from Pfizer, grants from BMS, grants from IPSEN, grants from EUSA Pharma, grants from MSD, grants from Sanofi, grants from Adacap, grants from Pierre Fabre, grants from Lexicon, grants from MTEM/THreshold, grants from Astra Zeneca, during the conduct of the study. <b>Dr. Porras</b> reports non-financial support from BMS, personal fees and non-financial support from Pfizer, non-financial support from AstraZeneca, personal fees and non-financial support from Merck, during the conduct of the study. <b>Dr. Ramón y Cajal</b> has nothing to disclose. <b>Dr. Trigo</b> reports personal fees and non-financial support from BMS, personal fees and non-financial support from AstraZeneca, personal fees from Bayer, non-financial support from MSD, personal fees from Takeda, personal fees from Eisai, personal fees from Merck, during the conduct of the study. <b>Dr. Iglesias</b> reports personal fees from Bayer, personal fees from Eisai, during the conduct of the study; personal fees from BMS, personal fees from Merck, personal fees from MSD, personal fees from Roche, personal fees from Sanofi, outside the submitted work. <b>Dr. Capdevila</b> reports grants and personal fees from Bayer, grants and personal fees from Eisai, grants from Astrazeneca, grants and personal fees from Advanced Accelerator Applications, grants and personal fees from Ipsen, personal fees from Novartis, personal fees from Pfizer, personal fees from Merck, personal fees from Sanofi, personal fees from Amgen, personal fees from Exelixis, outside the submitted work.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: For this type of study, informed consent is not required.